News Sentiment

BLAU3 sentiment intelligence

Blau Farmacêutica S.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 1 relevant articles
Exchange SAO Brazil
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 10.55 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

72/100 classification confidence.

Company focus 1

directly relevant article

Source quality 0

high-authority source matches

Trend context Trend inactive

+4.2% over one week, +7.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Medytox signs botulinum toxin distribution agreement worth USD 73 million with Blau Farmacêutica, from Brazil

Market Reaction

Price moving ahead of tone

55/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 72/100 classification
One-week reaction 4.2% Price confirming higher
Trend fit Trend inactive 7.2% over four weeks
Fair value 9.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 1
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 1
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MEDI:GATE NEWS 1

Event Lens

What the news is about

Classified themes
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-1 of 1